We care for children with a variety of allergic and immunologic disorders, and chronic respiratory diseases. Our highly specialized, board-certified clinicians diagnose and treat everything from the most common to the very rare conditions. Nasal and eye allergies Asthma Hives Medication allergy Chronic sinusitis Angioedema Hereditary angioneurotic edema Common variable immunodeficiency Secondary immune deficiencies Cystic fibrosis Sleep disorders Chronic lung disease in infants and older children Acute respiratory failure Treatments we offer include: Allergen vaccine immunotherapy (allergy shots) Asthma environmental controls and pharmacological controller therapy Intensive antihistamine regimens Biological therapy for hereditary angioneurotic edema Intravenous and subcutaneous immunoglobulin replenishment Aspirin desensitization Desensitization to antibiotics and other medications Our services include: Pediatric pulmonary function testing:We evaluate and follow lung disease in children with a full spectrum of tests, including diffusion analysis, challenge tests, and exercise. Physicians may order a pulmonary function test by calling 203-688-4667. Bronchoscopy:Bronchoscopy is the examination of the bronchi (the main airways of the lungs) using a flexible tube (bronchoscope). Bronchoscopy helps to evaluate and diagnose lung problems, assess blockages, obtain samples of tissue and/or fluid, and/or to help remove a foreign body. Bronchoscopies are performed in the pediatric operating room, and in the Pediatric Intensive Care Unit. Our pulmonologists who perform this procedure have extensive experience with flexible bronchoscopy, including its use in newborns. In many cases, flexible bronchoscopy, which can be safely and comfortably performed under conscious sedation, eliminates the need for an exam under general anesthesia.

The Center for Thoracic Cancers at Smilow Cancer Hospital consists of a multidisciplinary team of experts dedicated to providing evaluation of and treatment for patients with a thoracic malignancy, including lung cancer, esophageal cancer, thymoma, or chest wall tumors. Patients in Connecticut and beyond have access to nationally recognized expert clinicians, who provide an organized, collaborative approach to cancer care, as well as the latest technologies and treatments. Our team consists of a collaboration of specialty physicians, including medical oncology, radiation oncology, thoracic surgery, pulmonary medicine, digestive diseases, pathology, diagnostic imaging, and nursing. In addition to our expert clinicians, patients also receive comprehensive care to help with the physical, emotional, and psychological issues that are part of confronting cancer. Patients also benefit from the attention of the team's care coordinators, who make management of even the most detailed multidisciplinary treatment plan less complicated. Our team is active in clinical research, and focuses on developing advances to care in areas of thoracic oncology where the standard treatment needs improvement and where the optimal treatment approach remains unclear. To provide the best care, most of our patients are enrolled in a clinical trial where they can receive innovative therapy for their advanced disease, including immunotherapy, which was first used in clinical trials at Smilow Cancer Hospital. The Center for Thoracic Cancers offers second opinions that are easy, convenient, and all done remotely. Call (203) 200-LUNG for more information and learn how to schedule a second opinion appointment with one of our providers. Medical Oncology Our medical oncologists are nationally recognized for their leadership and expertise in lung cancer treatment and research, and are dedicated to offering personalized treatment options. Biomarker testing is often performed on the tumor to look for specific mutations that can be targeted by medication. There are currently FDA-approved lung cancer treatments for tumors showing abnormalities in EGFR, KRAS, ALK, ROS1, BRAF V600E, MET, RET , and NTRK genes. Recent studies conducted at Yale have led to FDA approval of drugs for the treatment of lung cancer, such as the immunotherapy drug Tecentriq (atezolizumab), which has been proven to improve patient survival for newly diagnosed NSCLC. This drug is designed to block PD-L1, a protein that was discovered by scientists at Yale and that has been instrumental in improving survival for lung cancer patients. Another FDA-approved drug, osimertinib, which stemmed from Yale Cancer Center and Smilow Cancer Hospital researchers, was approved for the treatment of adults with early-stage NSCLC with EGFR gene mutations. Surgery Many patients in need of surgery are referred for a minimally invasive surgery known as a video-assisted thoracoscopi

Our asthma and airway disease experts offer comprehensive, multidisciplinary treatment for a broad spectrum of conditions including: Treatment-resistant asthma Steroid-dependent asthma Steroid-resistant asthma Environmental and occupational asthma Exercise-induced asthma We frequently take care of patients with chronic cough, asthma that is difficult to control, as well as those whose condition is difficult to diagnose and who may be significantly affected by such co-occurring illnesses as gastroesophageal reflux, sinusitis, or vocal-cord dysfunction. We develop individualized care plans for all patients, with the goal of forming a working partnership with the referring primary care provider. Our skilled group includes three pulmonologists, one physician assistant, asthma nurse coordinators, and pulmonary function technicians trained in asthma education. We work closely with our colleagues in allergy and immunology, otolaryngology, gastroenterology and occupational and environmental medicine to coordinate an efficient and comprehensive process of evaluation for patients with complicated asthma. In conjunction with occupational and environmental medicine specialists, we may perform workplace or home environmental evaluations.